---
title: "Cor appoints Brent Pfeiffenberger to board as independent director"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286416248.md"
description: "Cor has appointed Brent Pfeiffenberger as an independent director on its board, effective May 13, 2026. Pfeiffenberger is currently the President & CEO of Century Therapeutics and has held senior roles at Neogene Therapeutics and Bristol-Myers Squibb. The appointment follows a recommendation from the Nominating and Corporate Governance Committee. Further details regarding board role changes were not disclosed."
datetime: "2026-05-14T12:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286416248.md)
  - [en](https://longbridge.com/en/news/286416248.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286416248.md)
---

# Cor appoints Brent Pfeiffenberger to board as independent director

**Cor appointed Brent Pfeiffenberger to its board of directors as an independent director, effective May 13, 2026.**

Individual

Brent Pfeiffenberger

Role

Member of the Board (independent)

Type of Change

Appointed

Effective Date

May 13, 2026

Reason

Appointment by Board recommendation of Nominating and Corporate Governance Committee

Replacement Info

Not disclosed

Background Details

President & CEO and director of Century Therapeutics since Dec 2023; chairman since Aug 2025; prior COO of Neogene Therapeutics (May 2021–Dec 2023); prior senior roles at Bristol-Myers Squibb; MBA (Wharton) and Pharm.D. (Duquesne)

Board/Committee Role Changes

Not disclosed

Original SEC Filing: Corbus Pharmaceuticals Holdings, Inc. \[ CRBP \] - 8-K - May. 14, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [IPSC.US](https://longbridge.com/en/quote/IPSC.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory](https://longbridge.com/en/news/293326979.md)
- [FDA accepts Bristol Myers NDA for mezigdomide in multiple myeloma, sets May 13, 2027 decision date](https://longbridge.com/en/news/292477087.md)
- [Bristol Myers Squibb: Low Volatility Meets High Dividend Yield](https://longbridge.com/en/news/284121828.md)
- [Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock](https://longbridge.com/en/news/288895535.md)
- [waypoint wealth counsel Buys Shares of 22,134 Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/283847222.md)